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Summary-It was observed that intraventricular (i.vt.) injection of HC-3 produced 
markedly different effects upon the EEG of the dog, dependent upon dose. The high dose 
(5 mg) investigated in this paper produced seizures with a 20 min latency. This effect was 
compared with the effects of several drugs known to act on the cholinergic system, and in 
addition the effect on acetylcholinesterase (AChE) of several brain regions was determined. 
It was concluded that the HG3-induced EEG seizures probably did not occur as a result of 
AChE inhibition but resulted from a direct action on possible cholinergic receptors. Sugges- 
tions for the nature of this action are discussed. 
INTRODUCTION 
HEMICHOLINIUM-3 (HC-3) has been both an exciting and disappointing pharmacological 
tool for those interested in central cholinergic mechanisms. Perhaps its greatest limitation 
is the difficulty with which it enters the brain (DOMER and SCHUELER, 1960) or consistently 
affects the central nervous system, even with large parenteral doses (DREN and DOMINO, 
1965). Although there are reports on the direct central actions of HC-3 given parenterally 
(SCHUELER, 1955; KASE and BORISON, 1958 and others) these effects are not widely accepted. 
The peripheral actions of HC-3 mask any central action the drug may have. 
In order to observe consistently the effects of HC-3 on the brain it is necessary to bypass 
the blood-brain barrier by injecting the drug either into the substance or ventricles of the 
brain. HEBB et al. (1964) injected HC-3 directly into the caudate nucleus of rats and 
found a marked and rapid (within minutes) reduction in acetylcholine (ACh) content and 
synthesis with little effect upon dopamine content. DREN and DOMINO (1965) injected 
HC-3 into the lateral ventricle of the paralyzed dog and found that the EEG of neocortical 
as well as subcortical structures was altered after approximately l-5-2.5 hr. Recently these 
investigators have reported that the EEG slowing was associated with a decrease in the 
ACh content of periventricular structures (DREN and DOMINO, 1966) over a wide dose 
range of HC-3. 
Large doses of HC-3, given intraventricularly (i.vt.) cause subcortical EEG seizures, 
which may spread to the cortex, prior to the time that the high voltage slow waves appear. 
This indicates that, as in peripheral tissues (SCHUELER, 1960), HC-3 has varying actions, 
dependent upon dose. If this agent is to be a useful tool for the investigation of central 
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cholinergic pathways, it becomes necessary to determine all of the possible cerebral actions 
of this drug upon i.vt. administration. 
In addition to its inhibitory effect on choline transport (GARDINER, 1961; VANDER, 
1962), HC-3 is reported to have both an anticholinesterase and a direct, curare-like 
action on the neuromuscular junction (SCHUELER, 1960). This paper describes the in vivo 
effects of HC-3 on acetylcholinesterase (AChE) in periventricular areas compared with 
the potent cholinesterase inhibitor, neostigmine. In addition, the effects of HC-3 on 
subcortical and cortical EEG have been compared with those agents which are classified 
as m and n cholinergic antagonists. An attempt has been made to characterize the nature 
of HC-3-elicited EEG seizures. This preliminary study suggests they are not the result 
of cholinesterase inhibition, but rather are due to a direct action on receptors which may 
be cholinergic in nature. 
METHODS 
EEG studies were performed in beagle-like mongrel dogs of either sex weighing from 
8-12 kg. The animals were paralyzed with decamethonium, intubated and artificially 
respired as described previously (DOMINO et al. 1967). The surgical procedures, which 
included placement of electrodes and cannulation of the femoral vein and artery, were 
performed under 70% nitrous oxide, 30% oxygen anesthesia. Subsequently, surgical 
sites were infiltrated with lidocaine (1%) plus epinephrine. The animals were thus main- 
tained in a pain-free, immobilized state. 
Electrodes were stereotaxically placed in cortical areas PrC, and Or, dorsal hippo- 
campus and the caudate nucleus on the left side of the brain, according to the dog brain 
atlases of LIM et al. (1960), and ADRIANOV and MERING (1964). Monopolar recordings 
were made, with reference to an indifferent electrode placed in the nasion, using the Offner 
type R Dynograph. The drugs listed in Table 1 were injected (i.vt.) through a needle 
placed into the left lateral ventricle above the dorsal hippocampus. The drugs were in 
0.9% saline solution and injected in a volume of 0.2 ml following the withdrawal of O-3 to 
O-4 ml of cerebrospinal fluid (csf). The needle was flushed with csf following the drug 
injection in such a manner that no change in ventricular volume occurred. 
TABLE 1. DRUGS GJSXN BY INTRAVENTIUCULAR ROUTE 
Drug* Dose in mg 
Molarity compared 
to 5.0 mg HC-3 No. of animals 
0.9 % NaCl - - 3 
NaBr 2.5 x2 3 
Hemicholinium-3 bromide (HC-3) 5.00 - 9 
Neostigmine bromide (NEO). 267 Equal 4 
0.0267 x 0.01 3 
Tetramethylammonium chloride (TMA) 1.78 x2 3 
Hexamethonium chloride (C,,) 2.45 Equal 3 
Atropine sulfate (ATRO.) 6.96 x2 6 
Atropine methyl nitrate 
Atropine methyl iodide (ME. ATRO.) 
7.30 x2 6 
d-Tubocurarine chloride (&TUBO.) 
*All drugs put into saline solution 
8.35 Equal 3 
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The animals were sacrificed by air injection at the time of development of a maximal 
pharmacological response, if one occurred. The head of each dog was rapidly cut in two, 
samples of brain taken for later AChE assay and immediately frozen in dry ice. At this 
time the location of the subcortical electrodes could be verified by gross observation. The 
areas sampled were: left caudate, thalamus, amygdala, hippocampus, sensory-motor and 
occipital cortex, as well as midline reticular formation ventral to the floor of the 4th ventricle. 
The cholinesterase assay was performed by the titrimetric method described by JENSEN- 
HOLM el al. (1959) using acetyl+methacholine (5 x 10-3M), as substrate to provide 
greater specificity for AChE. 
RESULTS 
Cqmparative eflects of i.vt. HC-3 and neostigmine 
The progression of EEG effects following 5 mg of HC-3 can be seen in Fig. 1. Approxi- 
mately 20 min after injection, spiking appeared in the subcortical leads. The site of origin 
of these spikes is subcortical, but the precise location is unclear as the spikes occasionally 
appeared simultaneously in both the caudate nucleus and hippocampus, and at other 
times began first in the caudate nucleus. In this report, it can be seen that 20 min after 
45 min 4.0 hr 
Fro. 1. EEG effects of a large dose of HC-3 given intraventricularly. Hemicholinium was 
given in a dose of 5 mg into the left ventricle. The animal was locally anesthetized and on 
artificial ventilation. Segments of the EEG record were taken before and at various times 
following HC-3, as indicated. Note that characteristic spike-like activity beginning in the 
caudate nucleus and hippocampus progressively increased in amplitude with the develop- 
ment of EEG seizures, particularly in the subcortical structures but projecting to the visual 
cortex as well. After 4 hr the characteristic high voltage, slow wave pattern was seen diffusely. 
All recordings are monopolar. Symbols: L.-left side; PrC,-precruciate cortex; 0,-O&- 
pita1 cortex; Dorsal Hipp-dorsal hippocampus; Caudate Nuc.-caudate nucleus; B. P.- 
arterial blood pressure in mm Hg. Time base and voltage calibrations are as indicated. 
These symbols apply to all subsequent figures. 
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injection, EEG spiking in the caudate nucleus is much better developed than in the hippo- 
campus. The spiking developed into seizures of relatively low frequency which spread to the 
occipital cortical lead. After 45 min, regardless of seizure origin, the hippocampus had 
the dominant activity and drove both the occipital cortex and caudate until the frequency 
of discharges became too great for the latter to follow. It was interesting to note that 
seizure discharge did not spread to the motor cortex. Most of the EEG leads were charac- 
terized by bursts of seizure activity of the type shown in the 40 to 50 min sequence until 
2.5 to 3-O hr after injection. At this time the EEG showed slow waves of the type pre- 
viously reported by DREN and DOMINO (1965, 1966), as shown in the 4 hr segment of 
record in Fig. 1. 
Figure 2 illustrates the development of the response to an equimolar dose (2.67 mg i.vt.) 
of neostigmine. The immediate postinjection phase was invariably characterized by 
constant them-like activity in the hippocampus. In 15-20 min this gave way to bursts of 
high voltage, high frequency activity which lasted 10-15 min. The EEG then showed a 
pattern of multiple spikes in the hippocampus and occipital cortex with slower high voltage 
activity in caudate and motor cortex shown in the I-hr panel in Fig. 2. 
The seizure activity caused by HC-3 became maximal within 30 min to 1 hr after injec- 
tion. It was felt that this latter time would be appropriate for determining the AChE 
activity of various periventricular and neocortical structures. Accordingly, animals were 





0 mm Hg 
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20 min I hr 
FIG. 2. EEG effects of neostigmine given intraventricularly. The effect of neostigmine in a 
dose equimolar to 5 mg of HC-3 is illustrated. Note that at 20 min marked EEG seizures are 
evident in the dorsal hippocampus, caudate nucleus and occipital cortex. This seizure activity 
continues but at a slower frequency 1 hr later. Note that the EEG effects of neostigmine 
are quite different from those of HC-3. 
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sacrificed 1 hr after the i.vt. injection of NC-3, equimolar neostigmine (2.67 mg or 0.01 
equimolar neostigmine, 267 pg), and the appropriate brain areas removed for assay. 
The latter dose was included because it is equimolar with the 50 pg dose of HC-3, which 
has been shown to cause EEG slowing and reduction of ACh levels comparable to the 
5 mg dose (DREN and DOMINO, 1966). The mean rfr SE of AChE activity of the various 
brain areas for groups of 3-9 animals are shown in Fig. 3. 
It can be seen that 5 mg of HC-3 injected i.vt. caused no measurable inhibition of 
AChE at 1 hr when the seizure activity was maximal. On the other hand, neostigmine, 
in an equimolar dose, caused marked AChE inhibition in both subcortical and cortical 
tissues and significant inhibition in subcortical areas at the 0.01 equimolar dose. 
q canhob(NaCI and NaBr) 
q HC-3 5mg 
Neotiigmine 267mg 
CoWbts WC nxJiomus Amygdolo Hippocampus Semc+y 
motor axiex Z%xW’ 
Retkular 
fomKIWl 
FIG. 3. Effects of HC-3 and neostigmine on brain acetylcholinesterase. AChE activity is 
expressed as pM of acetyl-fi methacholine hydrolysed per g of tissue per hr. The AChE activity 
of the caudate nucleus, medial thalamus, amygdala, ~p~pus, motor cortex, occipital 
cortex and reticular formation is indicated by the height of the bars. Control brain AChE 
activity is indicated after 0.9% sodium chloride and/or equimolar sodium bromide. The 
effects of large equimolar doses of HC-3 and neostigmine were compared to O-01 as much 
neostigmine. The standard deviations of the mean (S.E.) are indicated by the small vertical 
lines. The probabilities (student “t’* test, group comparison) are given when significant. 
Comparative e$ects of various drugs containing quaternary nitrogens 
It was possible that the seizure activity of HC-3 could be a relatively nonspecific ionic 
effect of the quatemary nitrogens. Therefore, the EEG effects of several quaterna~ 
compounds were compared with those of HC-3. Tetramethylammonium (TMA), the 
simplest of all quaternary nitrogen compounds, was administered in a twice equimolar 
dose (I.78 mg i.vt.) to obtain the same number of quaternary nitrogens as in HC-3. 
As shown in Fig. 4, TMA had no effect on either the cortical or subcortical EEG. The 
his-q~tern~ compound hex~etho~um, with a short six-carbon chain separating the 
cationic nitrogen structures, caused no generazed seizures but did result in spiking in 
the hippocampus when given in a dose (2.45 mg) which was equimolar to 5 mg of HC-3. 
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Administration of the bis-quaternary compound d-tubocurarine (g-35 mg i.vt.), resulted 
in almost immediate seizure discharge, as has been reported previously (FELDBERG 
et al., 1956). These seizures began subcortically and spread readily to the cortex. 
The increased n cholinergic effects that quaternization of atropine produces also facili- 
tated EEG seizures, (Fig. 5). The tertiary base atropine and its quaternary analogue, 
methylatropine, were administered i.vt. in twice equimolar doses (6.96 and 7.3 mg, 
respectively), to provide a number of quaternary or tertiary structures equal to those in 
HC-3. The first effect of atropine was a reduction of the amplitude of discharge in the 
hippocampus and caudate nucleus which may have been produced by the resulting extreme 
hypertension. This was followed by a gradual increase in the voltage of all leads at 25 min 
with a pattern greatly resembling sleep and including spindles in the motor cortex. By 
1 hr the EEG pattern showed spikes in the hippocamus and to a less extent in the occipital 
cortex; however, no EEG seizures were observed. 
Injection of methylatropine resulted in spiking within 5 min, and seizures within 15-min 
which seemed to originate subcortically and then spread to the cortex. This was in contrast 
to HC-3-induced EEG seizures which did not spread to the cortex in the doses used. 
All groups of animals were sacrificed, the pertinent brain areas assayed for AChE 
activity, and compared to HC-3 and neostigmine. Except for neostigmine, none of the 
compounds caused significant inhibition although atropine caused inhibition bordering 
on significance in the hippocampus with the large equimolar doses used. 
TMA 
Contrd 
2.45 mg ixt. 
I hr I hr 
FIG. 4. EEG effects of various quaternary drugs given intraventricularly. Typical EEG 
effects of various quaternary agents given in equimolar doses to 5 mg of HC-3 are illustrated. 
Note that the effects of tetramethylammonium (TMA), hexamethonium (C,) and d-tubo- 
curarine (d-Tubo) are quite different from those of HC-3. 
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Fro. 5. EEG effects of atropine and methylatropine given intraventricularly. Both drugs 
were given in twice equimolar doses to 5 mg of HC-3. Note that atropine produces some 
spiking and slow waves with spindles in PrC, at 25 min. In contrast methylatropine produces 
spiking followed by seizures resembling HC-3 seizures. 
DISCUSSION 
The results of the present study suggest that the EEG seizures resulting from i.vt. 
HC-3 probably are not brought about by AChE inhibition, nor are they the result of some 
non-specific effect of quaternary nitrogen compounds, since TMA failed to elicit 
seizures at twice equimolar doses. Indeed, the lack of seizures with hexamethonium and 
atropine indicate that the effect may depend upon the quaternary nitrogen associated 
with a large cyclic molecule. Furthermore, the differences in the characteristics of the 
seizures produced by the larger molecules, HC-3, d-tubocurarine and methylatropine, 
seem to indicate a degree of specificity in the site as well as mechanism of action. 
Unfortunately we cannot state unequivocally that cholinesterase inhibition does not 
occur with HC-3 in vivo. HC-3 is a competitive inhibitor (KURTZ et al., 1964) of low 
affinity and is readily displaced from the enzyme by the substrate. Thus, it would be possible 
for inhibition to occur in vivo which could not be measured in vitro due to dilution of the 
HC-3 during homogenization and displacement by the substrate. However, the conclusion 
that AChE inhibition does not occur to a significant degree can be supported by the observa- 
tion that the O-01 equimolar dose of neostigmine, which caused significant inhibition in 
the periventricular structures, did not consistently cause EEG seizures. In addition, the 
EEG seizures accompanying AChE inhibition by the equimolar dose of neostigmine were 
qualitatively very different from the HC3-induced seizures. Furthermore, the ACh- 
lowering effects are the same with 5 mg or 50 pg of HC-3 at 4 hr (DREN and DOMINO, 
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1966). It is unlikely that this would be true if the 5-mg dose caused significant AChE 
inhibition. 
Another factor indicating differences in the site or mechanism of action of these drugs 
is the time lag in the development of HC34nduced seizure discharge. Full development 
of seizures usually required 20-30 min with HC-3 and 12-15 min with methylatropine, 
whereas the d-tubocurarine seizures were maximal within 5 min. This time lag, noted with 
HC-3 in particular, is at variance with the observation of WINTE~RSTEIN (1961) that the 
response to i.vt. ad~istered drugs is usually quite rapid. In the case of the response 
to i.vt. d-tubocurarine, FELDBERG and FLEISCHHAUER (1963) have presented evidence 
that the primary site of action is the hippocampus. 
The time lag in the HC-3 seizure response may be due to either diffusion to a site other 
than the hippocampus or some cumulative effect with a fairly consistent time constant, 
or a combination of both. Consistent with the proposal of diffusion was the observation 
that spiking seemed to occur and become well developed in the caudate nucleus prior to 
development in the hippocampus. A more thorough investigation of the subcortical 
response is obviously needed to determine if this is the only site of origin of the EEG 
seizures and if the lag time is consistent with the time required to reach effective concen- 
trations of HC-3 by diffusion. 
The concept of a cumulative effect would seem, at first, to implicate the ACh-lowering 
effect of HC-3. The data of DREN and DOMINO (1966) show that, with 50 pg i.vt. HC-3 
at 1 hr, ACh levels are somewhat lower in the periventricular structures; however, only 
the effect on caudate is significant at the 0.05 level (Student’s “t” test, group compa~son), 
At this time there is no neocortical EEG effect. The eventual EEG effect of ACh-lowering 
is a high voltage slow wave pattern, not EEG seizures. In view of this, it seems unlikely 
that the seizures produced by a high dose of HC-3 are related to ACh-lowering, particularly 
since the 5-mg dose produces no greater lowering of ACh at 4 hr. 
HC-3 could be acting as an excitatory cholinergic agonist, as has been suggested recently 
by BARROS and DE BALBIAN VERSTER (1966). However, the time lag in onset of activity 
argues against this. It could also be acting to produce disinhibition by one of two possible 
mechanisms: by acting as an antagonist of an inhibitory mediator, or by blocking excitation 
of an in~bito~ system. Either of these mechanisms would result in increasing facilitation 
and recruitment of neurons eventually leading into seizure activity. 
In any event, HC-34nduced EEG seizure activity seems to be a direct effect of the drug 
qualitatively related to cholinergic blockade but differing somewhat from that produced by 
classic choline&c blockers, 
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